A series of novel N,N-disubstituted Et P-[2-(1H-indol-3-yl)acetyl]phosphoramidates were synthesized.All title compounds were characterized by IR, NMR (1H, 13C, 31P) spectra, mass spectra, and C, H, N anal.The anticancer activity of the title compounds was evaluated in two human cell lines MCF-7 (breast cancer) and HeLa (Cervical cancer) cell lines by the use of the MTT assay, and the IC50 values were determinedThe derivatives with substituted piperazines exhibited significant cytotoxicity against the tested cell lines at 5 μM and displayed low IC50 values in the region of 5.8-8.8 μM for MCF-7 cell lines and 14.8-16.4 μM for HeLa cell lines when compared with the standard doxorubicin (5.4 and 14.2 μM).